About Cardiomobile Egeszsegugyi Szolgaltato Kft.
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at Cardiomobile Egeszsegugyi Szolgaltato Kft.
During the past decade, Cardiomobile Egeszsegugyi Szolgaltato Kft. conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Phase II Efficacy Study Comparing 2',3'-Dideoxyinosine (ddI) (BMY-40900) and Zidovudine Therapy of Patients With HIV Infection Who Have Been on Long Term Zidovudine Treatment
Completed
750
An Efficacy Study of 2',3'-Dideoxyinosine (ddI) (BMY-40900) Administered Orally Twice Daily to Zidovudine Intolerant Patients With AIDS or AIDS-Related Complex
Completed
660
SCH 39304 as Therapy for Acute Cryptococcal Meningitis in HIV-Infected Patients Followed by Maintenance Therapy
Completed
50
A Randomized, Controlled Study of Intravenous Ganciclovir Therapy for Peripheral Cytomegalovirus Retinitis in Patients With AIDS
Completed
180
A Phase I/II Trial of Ribavirin (With Escalation) + Isoprinosine in Asymptomatic HIV-Viremic Patients
Completed
20
Chemotherapy and Azidothymidine, With or Without Radiotherapy, for High Grade Lymphoma in AIDS-Risk Group Members
1990-03-01
Completed
45
A Clinical Trial To Evaluate the Toxicity and Antiviral Effects of a Range of Doses of Ampligen in p24 Antigen Positive HIV-Infected Patients With AIDS or ARC
1990-02-01
Completed
12
Safety and Efficacy of Zidovudine for Asymptomatic HIV-Infected Individuals
1995-02-01
Completed
3,200
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at Cardiomobile Egeszsegugyi Szolgaltato Kft.
According to Clinical.Site data, the most researched conditions in "Cardiomobile Egeszsegugyi Szolgaltato Kft." are
"Atrial Fibrillation" (1 trials), "Heart Failure" (1 trials) and "Prevention of Stroke or Systemic Embolism" (1 trials). Many other conditions were trialed in "Cardiomobile Egeszsegugyi Szolgaltato Kft." in a lesser frequency.
Clinical Trials Intervention Types at Cardiomobile Egeszsegugyi Szolgaltato Kft.
Most popular intervention types in "Cardiomobile Egeszsegugyi Szolgaltato Kft." are "Drug" (2 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Apixaban" (1 trials), "Apixaban matching placebo" (1 trials), "Asundexian (BAY2433334)" (1 trials), "Asundexian matching placebo" (1 trials) and "Finerenone (BAY94-8862)" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Cardiomobile Egeszsegugyi Szolgaltato Kft.
The vast majority of trials in "Cardiomobile Egeszsegugyi Szolgaltato Kft." are
2 trials for "All" genders.
Clinical Trials Status at Cardiomobile Egeszsegugyi Szolgaltato Kft.
Currently, there are NaN active trials in "Cardiomobile Egeszsegugyi Szolgaltato Kft.".
undefined are not yet recruiting,
1 are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were undefined completed trials in Cardiomobile Egeszsegugyi Szolgaltato Kft.,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Cardiomobile Egeszsegugyi Szolgaltato Kft., 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 2 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".